In August this year, Latvia received more than 50,000 doses of the Comirnaty LP.8.1 vaccine from the manufacturer, adapted to the Covid-19 variants circulating this season, the National Health Service (NVD) reports.
Of these, 46,080 doses are intended for individuals aged 12 and older, 2,880 doses for children aged 5–11, and 1,440 doses for infants and children aged six months to four years.
At the same time, Comirnaty vaccines adapted to the Covid-19 strains circulating in the 2024/2025 season — Comirnaty JN.1 and Comirnaty KP.2 — remain available for vaccination.
Healthcare providers, including family doctors and vaccination centers, can order the vaccines for their patients to ensure seasonal immunization. Several clinics and family practices have already ordered and received the updated Covid-19 vaccines.
The Centre for Disease Prevention and Control (SPKC) is urging doctors and healthcare institutions to actively participate in seasonal Covid-19 vaccination and to ensure access for high-risk patients.
People recommended for vaccination can contact their family doctor.
If the vaccine is not yet available, the doctor can order it. Deliveries are organized twice a month.
With Covid-19 cases on the rise, SPKC is urging individuals at increased risk of severe illness to get the seasonal shot.
The latest epidemiological data still indicate a growing spread of Covid-19 and a worsening situation. The proportion of positive tests has risen from 8% in the first week of August to 17.3% in the last week of the month. Hospital admissions with Covid-19 have also increased: from eight patients in the first week of August to 48 in the last week. Three deaths were reported in August among patients with confirmed Covid-19 infection. Wastewater monitoring results also confirm an increase in virus circulation at the end of summer.
According to SPKC, a similar epidemiological trend was observed last year, with a Covid-19 surge in late summer and early autumn.
SPKC stresses that vaccination is especially recommended for people at high risk of severe illness
— including all residents aged 65 and older, patients with moderate or severe immunosuppression (including adolescents and children from six months of age), adults with serious chronic illnesses, and pregnant women. Vaccination is also advised for those who provide daily care for seniors or people with serious health conditions.
SPKC emphasizes that vaccination reduces the risk of severe illness, hospitalization, and death from Covid-19.
Latvian data confirm this: an SPKC analysis of the 2024/2025 vaccination season showed that the risk of hospitalization due to Covid-19 was 2.3 times higher, and the risk of death 3.1 times higher, among seniors who were not vaccinated compared to those who were.
Monitoring data show that during the previous vaccination season (from August 1, 2024, to March 25, 2025), 22,217 people in Latvia were vaccinated against Covid-19, including 15,059 individuals aged 60 and older — 2.8% of the population in that age group.
Read also: Vaccination stalls; scientists call to action